MNBTD
ONCE

Moody National Bank Trust Division’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Moody National Bank Trust Division’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-51
Closed -$6K – 1144
2019
Q1 		$6K Sell
51
-58
-53% -$4.26K ﹤0.01% 843
2018
Q4 		$4K Buy
+109
New +$4.73K ﹤0.01% 1046

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Moody National Bank Trust Division's ONCE Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 51 shares — an estimated $6K sold.

Moody National Bank Trust Division first reported a position in ONCE in Q4 2018 and held it in 2 quarters. The position peaked at $6K in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 51 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $6K.
  • Moody National Bank Trust Division first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's Spark Therapeutics, Inc. Common Stock position peaked at $6K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.